SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

   Strategies & Market TrendsSpeculating in Takeover Targets


Previous 10 Next 10 
To: richardred who wrote (2004)1/25/2011 12:10:15 PM
From: richardred
   of 6100
 
CTS Completes Acquisition of Fordahl SA
blue line
Source: BW
Date: 09:09 AM
blue line

01/25 09:09 CTS Completes Acquisition of Fordahl SA

Expands CTS' Precision Frequency Electronic Component Products in Europe

ELKHART, Ind.--(BUSINESS WIRE)--January 25, 2011--

CTS Corporation (NYSE: CTS) today announced the completion of the acquisition of certain assets and liabilities of Fordahl SA, a privately held company located in Brugg, Switzerland. Fordahl is a leader in the design and manufacture of precision frequency crystal oscillators. On December 16, 2010, CTS Corporation announced that it had signed a definitive agreement for this acquisition. The acquisition will expand CTS' technology and customer base within the Components and Sensors segment.

About CTS

CTS is a leading designer and manufacturer of electronic components and sensors and a provider of electronics manufacturing services (EMS) to OEMs in the automotive, communications, medical, defense and aerospace, industrial and computer markets. CTS manufactures products in North America, Europe and Asia. CTS' stock is traded on the NYSE under the ticker symbol "CTS." To find out more, visit the CTS Web site at www.ctscorp.com.

Share RecommendKeepReplyMark as Last Read


To: richardred who wrote (2657)1/25/2011 12:19:17 PM
From: richardred
   of 6100
 
DJ UPDATE: Savient Names Pres Of Lilly's Ocology Division As CEO
blue line
Source: DJ
Date: 11:18 AM
blue line

01/25 11:18 DJ UPDATE: Savient Names Pres Of Lilly's Ocology Division As CEO

DOW JONES NEWSWIRES

Savient Pharmaceuticals Inc. (SVNT) said it named Eli Lilly & Co. (LLY) executive John H. Johnson to its chief executive post, a role the company hasn't had since late 2008.

The announcement came about a month after Savient said its board had started a search to fill the position, which was left vacant when Christopher G. Clement resigned in an "involuntary termination by the company without cause," according to a regulatory filing at the time.

Johnson was a senior vice president of Eli Lilly and president of that company's oncology business unit. From August 2007 to November 2009, he was CEO of ImClone Systems, which was acquired by Lilly for $6.5 billion in late 2008. Before joining ImClone, Johnson was an executive at Johnson & Johnson's (JNJ) worldwide biopharmaceuticals unit.

The appointment comes as the company has been working to commercialize Krystexxa, gaining approval from the U.S. Food and Drug Administration in September. The drug was first approved in the U.S. to treat chronic gout patients who don't respond to standard therapy. Savient has said it continues to believe it's on track to launch Krystexxa early this year.

On Tuesday, Chairman Stephen O. Jaeger said the company believes Johnson is the candidate to help bring Krystexxa to market "and realize this novel drug's full potential." Johnson will also serve as a member of Savient's board.

Savient also said President Paul Hamelin, the company's most senior executive, would remain at Savient throughout a transition period and then will leave to pursue other interests.

Meanwhile, Lilly said a successor to Johnson will be announced in the coming weeks.

"Given his previous post at ImClone, John has played a key role leading the integration efforts since Lilly's acquisition," Lilly Chief Executive John Lechleiter said.

The ImClone acquisition broadened Lilly's oncology portfolio and strengthened its pipeline and biotech capabilities. Its sole product on the market at the time was Erbitux, which is approved to treat colon and head and neck cancers.

Savient shares were up 1.6% at $10.06 in recent trading, while Lilly was off 0.4% to $34.65.

-By John Kell, Dow Jones Newswires; 212-416-2480; john.kell@dowjones.com

Lilly-Historical Imclone connection-My thoughts of a someday Lilly acquisition, might be possible after all.

snip>John H. Johnson, ImClone's chief executive officer, said "We believe this is an important step forward in ImClone's and Lilly's shared goal of addressing the medical needs of cancer patients around the world. The significant progress ImClone has made over the last few years is a direct result of the important contributions of our employees, and joining forces at this stage of our growth will allow us to leverage Lilly's global capabilities and make even greater advancements in our proprietary pipeline."
Message 26987722

Message 26915038

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


From: richardred1/25/2011 12:50:51 PM
   of 6100
 
ISS-FWIW-I own some of the acquiring company. Purchased in Dec 2010.

DJ Integrated Silicon To Buy Si En Integration For $20 Million
blue line
Source: DJ
Date: 01/24/11
blue line

01/24 16:52 =DJ Integrated Silicon To Buy Si En Integration For $20 Million

DOW JONES NEWSWIRES

Integrated Silicon Solution Inc. (ISSI) agreed to buy China-based Si En Integration Holdings Ltd. in a $20 million cash deal the semiconductor maker said will diversify its product portfolio.

Integrated Silicon said the transaction would allow the company to obtain higher-margin analog and mixed-signal products, while strengthening the company's overall business and presence in the growing Chinese market. The Si En deal will also expand Integrated Silicon's market share with existing and new customers, the company said.

The acquisition is expected to close in the current quarter. Integrated Silicon believes the purchase will immediately add to earnings.

Founded in 2005, privately held Si En posted revenue of $22.2 million, gross margin of 42.5% and operating income of $5.2 million for the year ended Dec. 31. Si En targets the mobile communications, digital consumer, networking and automotive markets. Si En's primary products are audio amplifiers, LED drivers, power management and temperature sensors.

Integrated Silicon has noted it has seen weaker demand lately. Earlier this month, the company cut its fiscal first-quarter outlook, citing weaker-than- expected demand for its random-access memory products.

Integrated Silicon's shares closed up 2.3% to $9.51 and were inactive in after-hours trading.

-By John Kell, Dow Jones Newswires; 212-416-2480; john.kell@dowjones.com

Click here to go to Dow Jones NewsPlus, a web front page of today's most important business and market news, analysis and commentary: http:// www.djnewsplus.com/nae/al?rnd=tQEtaKD5hMUtDy%2BfDyNLqw%3D%3D. You can use this link on the day this article is published and the following day.

(END) Dow Jones Newswires

01-24-11 1652ET

Copyright (c) 2011 Dow Jones & Company, Inc.

Share RecommendKeepReplyMark as Last Read


From: richardred1/25/2011 1:53:35 PM
   of 6100
 
For those who might look in here. I'll be be away from my PC & SI for a couple weeks.

GITY-Good Investing to You
Rick

Share RecommendKeepReplyMark as Last Read


To: Brasco One who wrote (2556)2/18/2011 5:48:55 AM
From: richardred
   of 6100
 
Nice call on MEE. I've Been looking to buy some SEE, in the packaging sector that is.

Share RecommendKeepReplyMark as Last Read


From: richardred2/18/2011 9:14:20 AM
   of 6100
 
I've been away from SI for these past couple of weeks. I have a little bit of cometary today for witch I'm usually short on in my posts. Yeah, it's a little bit of a rant, but I don't rant on to often, and it does relate to my investing theme. I will even have some political blurbs today as it also does apply to my investing scenario. I've changed my cautious sentiment, to being outright very bullish, and also being more diversified. I'm getting close to being 100 % fully invested. Of coarse, I could be wrong. There are more than a couple of reasons for my sentiment change. First off, world events. Freedom is a powerful thing. It's starting to spread. In high school. I believe it's was called the domino effect. In theory, I believe, if Egypt goes so will others like her. I've not been watching world news, so they most likely are already starting to mention this. I've mentioned here at SI in the past it's not the Iranian people. It's their leadership. I have to ask myself . Why wouldn't most Iranian people want freedom of religion , free elections, and free speech, also freedom for their women? Freedom of religion is one reason why people came to this country, or so I was taught.
I sense the leadership in other non free Arab countries are scared for what is going on. Who are the friends of such countries. China, Venezuela, North Korea, Russia are some. Let me see, not exactly to much freedoms in those countries. Of coarse so is the US a friend, and other free nation countries. The US still has freedoms in our country, our forefathers drafted. The process is still working for over 200 years now.

The second reason for my bullish stance is President Obama stance on business. It's become more positive. IMO it's what businesses were waiting to hear. IMO Plain and simple. It comes down to that never ending political statement. "IT'S THE ECONOMY STUPID". If such political actions and others that might be forthcoming put people back to work. President Obama could be a bigger force than first thought come re-election time. If the situation doesn't improve that much. IMO- There are three wise men waiting in the wings. Their names are Ron Paul, Steve Forbes, and Mitt Romney.

The third reason is gold. To much PR on owning it, and why you should own it. IMO think food. As some others have mentioned. In a natural disaster witch would you rather have? Food is also my major sector additions to my portfolio. Adds to CAG CPB LNCE
food Message 24489261

gold-eagle.com

The forth reason is the Packers won the Superbowl. The Superbowl Theory. That is if you believe in that sort of thing. The NFC team must win for the stock market to go up.<G> :+ )

I Still might be out of SI Awhile longer as I have been blessed with a new granddaughter about six months ago. I Will be converting our dining room into a bedroom for our daughter. My father in law to help with the conversion.

Other Portfolio additions or adds AVP NCR OLN SVNT LNDC BKE

One notable- Sold out of UFPT yesterday witch was my biggest holding and biggest windfall year to date. Yep, I most likely sold to early, but I'm not looking a gift horse in the mouth. A very wise man once told me.

Share RecommendKeepReplyMark as Last ReadRead Replies (5)


To: richardred who wrote (2732)2/19/2011 12:00:55 AM
From: richardred
   of 6100
 
Forgot to mention two other SITT additions. HRS And added to ULBI after this quarters reported loss.

Share RecommendKeepReplyMark as Last ReadRead Replies (2)


To: richardred who wrote (2733)2/19/2011 2:15:06 AM
From: richardred
   of 6100
 
By gosh I forgot one more, SNDK.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: richardred who wrote (2733)2/22/2011 10:32:10 PM
From: Paul Senior
   of 6100
 
Following you into HRS today.
----------------------
Betting that there will be a takeout offer for BIG at higher than $41/sh, I added to my small BIG position.

Share RecommendKeepReplyMark as Last ReadRead Replies (1)


To: richardred who wrote (2732)2/23/2011 3:57:45 AM
From: ~digs
   of 6100
 
heads up fwiw,

not sure why the relative weakness, but OLN has shown up on my anti momo scan

Share RecommendKeepReplyMark as Last ReadRead Replies (1)
Previous 10 Next 10